Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$3.53 - $5.5 $57,892 - $90,200
-16,400 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$4.99 - $6.55 $56,387 - $74,015
-11,300 Reduced 40.79%
16,400 $82,000
Q2 2021

Aug 16, 2021

BUY
$6.24 - $8.22 $172,848 - $227,694
27,700 New
27,700 $181,000
Q1 2021

May 17, 2021

SELL
$6.74 - $10.95 $8,088 - $13,140
-1,200 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$3.75 - $10.56 $4,500 - $12,672
1,200 New
1,200 $12,000
Q3 2020

Nov 16, 2020

SELL
$3.5 - $6.2 $228,550 - $404,860
-65,300 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$2.16 - $5.46 $144,936 - $366,366
-67,100 Reduced 50.68%
65,300 $326,000
Q1 2020

May 15, 2020

BUY
$1.46 - $7.19 $193,304 - $951,956
132,400 New
132,400 $450,000

Others Institutions Holding PGEN

About PRECIGEN, INC.


  • Ticker PGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 208,150,000
  • Market Cap $156M
  • Description
  • Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...
More about PGEN
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.